Hyperfine (NASDAQ:HYPR) Shares Down 6.8% – Should You Sell?

Hyperfine, Inc. (NASDAQ:HYPR) dropped 6.8% during mid-day trading on Monday . The stock traded as low as $0.9250 and last traded at $0.9277. Approximately 3,219,550 shares changed hands during trading, an increase of 501% from the average daily volume of 536,113 shares. The stock had previously closed at $0.9959.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a report on Wednesday, October 8th. Wall Street Zen raised Hyperfine from a “sell” rating to a “hold” rating in a report on Saturday, October 25th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $1.28.

Hyperfine Stock Down 6.8%

The company has a market cap of $90.14 million, a P/E ratio of -1.78 and a beta of 1.08. The business has a 50-day moving average price of $1.22 and a two-hundred day moving average price of $1.13.

Hyperfine (NASDAQ:HYPR) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01). Hyperfine had a negative net margin of 378.17% and a negative return on equity of 97.95%. The business had revenue of $3.44 million during the quarter, compared to the consensus estimate of $3.51 million. As a group, sell-side analysts expect that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

Several hedge funds have recently bought and sold shares of HYPR. EP Wealth Advisors LLC bought a new position in shares of Hyperfine during the 1st quarter valued at about $25,000. Vanguard Group Inc. boosted its stake in shares of Hyperfine by 5.7% during the 3rd quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock worth $5,092,000 after buying an additional 190,136 shares during the last quarter. Finally, Tortoise Investment Management LLC bought a new position in Hyperfine in the third quarter valued at approximately $65,000. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.